8k8 casino register app

FOR Heart Evangelista, eyeliners are serious business. As a chinita, her eye shape changes. “If you know, you know the difference of brown, light brown, and black liquid liners. That’s my obsession. I am very particular with my eyeliner and how the liquid liner blends with a pencil liner,” said the actress, host and global fashion influencer during a press conference to announce her as GRWM Cosmetics’ new endorser. In particular, Heart singles out GRWM’s Super Fine Liner Duo as one of her favorite products from the brand. The #HeartMadeMeBuyIt is very popular on social media and this is naturally one of the reasons why GRWM Cosmetics reached out to the actress. “The first time we saw that she [Heart] used our Brow Lift, talagang nagbunyi kami sa buong company [we all celebrated]. She is really perfect for our eye collection. When you say eye makeup, eyeliner, talagang [it is Heart] ’yung naiisip,” said GRWM Cosmetics founder, chief product officer, chief marketing officer and CEO Mae Layug Madriñan. Her fans like to say that Heart’s face card never declines and it is true. From her teenage years up to today, Heart is considered one of the most beautiful faces of Philippine entertainment, and in the fashion, and beauty industries. More than beauty, Madriñan said she is happy that GRWM Cosmetics and Heart Evangelista share the same values when it comes to animal welfare. The GRWM CEO is an advocate for animal welfare and sustainable practices, and has been a driving force behind numerous initiatives to promote animal welfare. “Our shared passion for animal welfare creates a powerful alliance, driving change and inspiring everyone to make a difference,” said Madriñan. Heart is an animal rights advocate who uses her platform to raise awareness about the need to support aspins. “It is a pleasure to be part of GRWM. I was genuinely moved by their innovative approach to beauty, inclusivity, especially their commitment to animal welfare, and our shared goal of empowering Filipina beauty,” said Heart. The press conference was held at the sidelines of the GRWM Ball 2024 during which GRWM Cosmetics introduced their mega collection, called “Face Card.” I will be talking about this collection in the future. The Face Card Collection will launch this November 29 on GRWM Cosmetics’ e-commerce platforms. The products will also launch in Watsons stores. REVLONISSIMO COLOR SUBLIME IS HIGH-PERFORMANCE HAIR COLOR Revlonissimo Color Sublime stands at the forefront of innovation with its ammonia-free color system, designed to reflect not only your style but also your commitment to natural, clean beauty. Revlonissimo Color Sublime showcases two categories of shades. The Natural Shades—6 Dark Blonde, 5 Light Brown, 4 Medium Brown, and 3 Dark Brown—are designed to complement Asian hair, offering rich, natural-looking results that enhance the beauty of darker tones. Meanwhile, the Cool Shades are in 7.1 Medium Ash Blonde, 6.1 Dark Ash Blonde, and 5.1 Light Ash Brown. Revlonissimo Color Sublime goes beyond just color, offering up to 100 percent gray coverage and long-lasting color. The formula ensures even color results with every application and is composed of up to 87 percent naturally derived ingredients and 96 percent biodegradable ingredients. This advanced system also delivers optimal scalp comfort and nourishment. The Dual-Action Vegan Color System is infused with natural cold-pressed oils like sunflower and coconut, so it nourishes the hair fiber while locking in moisture and strengthening the hair for luminous, natural-looking color with light reflection properties. Treat yourself to a stunning new look with Revlonissimo Color Sublime at top salons in the Philippines like Studio Fix by Alex Carbonell and Bench Fix Salon. Professional stylists at these salons use the full potential of the Revlonissimo Color Sublime range to make sure your hair is healthy and gorgeous. For salons looking to offer this exceptional color line, Revlonissimo Color Sublime is exclusively distributed by New Summit Colors Distribution Inc. For inquiries, contact sales@newsummitcolors.com. Image credits: Sparkle GMA Artist Center Dinna Chan Vasquez is a columnist, writer, mother, wife, HIV awareness advocate and protector of animals.8k8 casino register app 。

VANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) — Atelier Meats Corp. (the “ “) is pleased to announce a proposed brokered private placement of special warrants of the Company (each, a “ “), to be conducted by Canaccord Genuity Corp., as the sole agent, (the “ “) on a commercially reasonable best efforts basis, pursuant to which the Company will offer at least 6,000,000 Special Warrants at a price of $0.50 per Special Warrant (the “ “) for gross proceeds of at least $3,000,000 (the “ “). Concurrently with the Brokered Offering, the Company intends to complete a non-brokered offering of Special Warrants at the Offering Price for gross proceeds of at least $1,000,000 on the same terms as the Brokered Offering (the “ “, collectively with the Brokered Offering, the “ “). Each Special Warrant will entitle the holder thereof to receive, without any further action on the part of the holder or payment of any additional consideration, one unit of the Company (each, a “ “). Each Unit shall consist of one common share in the capital of the Company (a “ “) and one Common Share purchase warrant (a “ “). Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of $0.60 at any time prior to the date that is 24 months from the Closing Date (as defined herein). All unexercised Special Warrants will automatically be exercised into Units on the ‎day (the “ “) that is the earlier of (i) four (4) months ‎and a day following Closing Date (as ‎defined herein), and (ii) as soon as ‎reasonably practicable, and in any event no later than the third (3rd) ‎business day, after a receipt is issued for the Final Prospectus (as defined herein). The Company will‎ prepare and file a preliminary prospectus and a final ‎‎prospectus (the “ “) with each of the securities ‎regulatory ‎authorities in the provinces of Canada in which the Special ‎Warrants are sold (the ‎‎” “) and obtain a receipt thereof, ‎qualifying the distribution of the Units underlying the Special ‎Warrants, ‎in compliance with applicable securities law. In the event that the Company has not received a receipt for the Final ‎Prospectus within 60 days following the Closing Date, each ‎unexercised Special Warrant will thereafter entitle the holder thereof to ‎receive upon the exercise thereof, at no additional consideration, one-‎and-one-tenth (1.10) Unit (instead of one Unit) (the additional ‎Units are ‎collectively referred to as “ “). ‎Any ‎fractional entitlement to Penalty Units will be rounded down to the ‎‎nearest whole Penalty Unit‎.‎ The Company has agreed to pay the Agent a commission equal to 7.0% of the aggregate proceeds of the Brokered Offering payable in cash or Special Warrants, or any combination of cash or Special Warrants at the sole option of the Agent (“ “), as well as a corporate finance fee of $100,000 payable in cash (“ “). In addition, subject to compliance with all required regulatory approvals, the Company will issue to the Agent such number of compensation options (each, an “ “) as is equal to 7.0% of the aggregate Special Warrants sold under the Brokered Offering, each of which will entitle the Agent to purchase one Unit at the Offering Price at any time prior to the date that is 24 months from the ‎Closing Date. The Special Warrants will be offered for sale to purchasers in: (i) all provinces of Canada, except Quebec, pursuant to available private ‎placement exemptions under National Instrument 45-106 ; (ii) the United States on a private placement basis pursuant to available exemptions from the registration requirements under the , as amended (“ “); and (iii) offshore jurisdictions agreed upon between the Company and the Agent pursuant to available prospectus or registration exemptions in accordance with applicable laws. Closing of the Offerings is expected to take place on such date or dates as agreed to by the Company and the Agent (the “ “), but closing of the Non-Brokered Offering may take place at a different time and/or date from that of the Brokered Offering, in the Company’s sole discretion. The net proceeds of the Offerings will be used for advancing the development of patents and products, continuing the new product research and development with the University of Rutgers for commercialization including making outstanding payments to the University of Rutgers, for expenses relate to the Offering as well as marketing and general working capital. The Offerings are intended to be undertaken in connection with the Company’s proposed direct listing of its common shares on the Canadian Securities Exchange (“ “) (the “ “). The Company is a reporting issuer in Alberta and British Columbia. The Special Warrants will be issued pursuant to a private placement and until a receipt is issued for the Final Prospectus, the Special Warrants will be subject to a hold period under applicable Canadian securities laws expiring on the date that is four months and a day following the Closing Date. It is a condition of the proposed Transaction that the Company receive all required board, shareholder, third party, and regulatory approvals, as applicable, and that the Company receives conditional approval to list its common shares on the CSE. In connection therewith, the Company has filed a listing application with the CSE, in accordance with the policies of the CSE. Upon listing, it is expected that the Company’s common shares will trade under the ticker symbol “STKK”. This news release does not constitute an offer to sell or a solicitation of an offer to sell any securities of the Company in the United States. The securities of the Company have not been and will not be registered under the U.S. Securities Act or any state securities laws and may not be offered or sold within the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Atelier Meats Corp. stands out in the cultured meat industry with its groundbreaking scaffold technology, designed to address the key challenge of scalability that has hindered many other companies. By providing a structural framework for lab-grown cells to grow into complex meat cuts, the Company’s proprietary solution enables the efficient and cost-effective production of high-quality cultured meat at scale. With two pending patents, the Company’s technology offers a competitive edge and a licensing model that could empower other companies in the industry to overcome scalability obstacles. This positions the Company as a vital player in driving the cultured meat sector toward widespread adoption and market viability. Leighton Bocking Interim Chief Executive Officer and Director Email: Website:Evolution AB: The Sin Stock That Can Spike Your Dividend Income

The U.S. says it pushed retraction of a famine warning for north Gaza; Aid groups express concern

Bears keep GM Ryan Poles in driver's seat for coaching search"We had another outstanding quarter with record revenue and positive Adjusted EBITDA...We are very excited with our VSDHOne release and onboarding clients to increase our growth pace” - Shane Madden, CEO of Hydreight VANCOUVER, British Columbia and LAS VEGAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (" Hydreight ” or the "Company ”) ( TSXV: NURS )( OTCQB: HYDTF )( FSE: SO6 ), a fast-growing mobile clinical network and medical platform which enables flexible at-home medical services across 50 states in the United States, is pleased to announce its financial results for the third quarter ended September 30, 2024. All financial information is presented in Canadian dollars unless otherwise indicated. Summary of Q3, 2024 Financial Highlights: The Company believes the following Non-GAAP 1 financial measures provide meaningful insight to aid in the understanding of the Company's performance and may assist in the evaluation of the Company's business relative to that of its peers: The table below sets out a summary of certain financial results of the Company over the past eight quarters and is derived from the audited annual consolidated financial statements and unaudited quarterly consolidated financial statements of the Company. After Taxes Income (Loss) Income (Loss) Per Share The Company has experienced dramatic user growth over the past two years as can be seen by the consistent revenue growth over the past eight quarters. The Company continues to deliver on its mission of building one of the largest mobile clinical networks in the United States. Through its medical network, pharmacy network and proprietary technology platform that adheres to the complex healthcare legislation across 50 states, Hydreight has provided a fully integrated solution for healthcare providers to become independent contractors. Hydreight remains focused on its strategic priorities of (1) Profitability (2) adding more product and service offerings for its customers, (3) introducing Hydreight story with more potential shareholders (4) driving white label partnerships and Nurses to the platform and (5) looking for strategic tuck in M&A opportunities to scale and grow the business quickly and efficiently . Hydreight will continue to invest into its technology to ensure continuous improvements, advancements and updates adhering to changes within the healthcare industry. Please see SEDAR + for the Company's condensed interim consolidated unaudited financial statements and MD&A for the three and six months ended September 30, 2024 and 2023 and for the Company's audited annual consolidated financial statements and MD&A for the year ended December 31, 2023 and 2022. About VSDHOne - Direct to Consumer Platform In a partnership with two other parties, Hydreight Technologies launched the VSDHOne (Read as VSDH-One)platform. VSDHOne simplifies the entry challenges for companies and medi-spa businesses to enter the online healthcare space compliantly. This platform will help all businesses to launch a direct-to-consumer healthcare brand in a matter of days in all 50 states. Compliant offerings include: GLP-1s (semaglutide, tirzepatide), peptides, personalized healthcare treatments, sermorelin, testosterone replacement therapy ("TRT”), hair loss, skincare, sexual health and more. Hydreight invested in technology, legal and infrastructure to launch this platform. The VSDHOne platform offers a complete, end-to-end solution for businesses looking to launch direct-to-consumer healthcare brands. From compliance and telemedicine technology to nationwide doctor and pharmacy networks, VSDHOne provides all the tools needed for a seamless entry into the online healthcare space. The platform is designed to significantly reduce the time and costs associated with launching such services, making it possible for businesses to go live in days instead of months. About Hydreight Technologies Inc. Hydreight Technologies Inc. is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network. On behalf of the Board of Directors Shane Madden Director and Chief Executive Officer Hydreight Technologies Inc. Contact Email: [email protected] ; Telephone: (702) 970 8112 This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements. Use of Non-GAAP Financial Measures: This release contains references to non-GAAP financial measures Adjusted Revenue (also referred to as Topline Revenue), Adjusted Gross Margin, and Adjusted EBITDA. The Company defines Adjusted Revenue as gross cash income before adjustment for the deferred portion of business partner contract revenue and gross receipts from Hydreight App service sales. The Company defines Adjusted Gross Margin as GAAP gross margin plus inventory impairment plus the deferred portion of business partner contract revenue. The Company defines Adjusted EBITDA as net income (loss) before interest, taxes, depreciation and amortization and before (i) transaction, restructuring, and integration costs and share-based payments expense, and (iii) gains/losses that are not reflective of ongoing operating performance. The Company believes that the measures provide information useful to its shareholders and investors in understanding the Company's operating cash flow growth, user growth, and cash generating potential for funding working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. These non-GAAP measures may assist in the evaluation of the Company's business relative to that of its peers more accurately than GAAP financial measures alone. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP and is not necessarily indicative of other metrics presented in accordance with GAAP. Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements. Cautionary Note Regarding Forward-Looking Information This press release contains statements which constitute "forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, path to profitability, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may”, "would”, "could”, "should”, "will”, "intend”, "plan”, "anticipate”, "believe”, "estimate”, "expect” or similar expressions and includes information regarding expectations for the Company's growth and profitability in 2024. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company's management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company's shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law. 1 See Use of Non-GAAP Financial MeasuresITV I'm A Celebrity fans 'gutted' that things in the jungle are going to change